EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin D status in patients treated for prostate diseases in a tertiary hospital, in Calabar, south-south, Nigeria

Eyam ES, Eyam LE, Ene AB, Inyang OG, Saidu K, Oaclayanju O

Ibom Medical Journal · 01.07.2026 · 19 (3) · 669-676

DOI: 10.61386/imj.v19i3.1198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ibom Medical Journal, online erschienen am 01.07.2026. Verfasst von Eyam ES und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Vitamin D deficiency is a global problem often undiagnosed among patients, and routine monitoring is not practiced in Nigeria.

Objective

We assessed the vitamin D status of patients undergoing treatment for prostate diseases in Calabar.

Methods

A descriptive cross-sectional study of 102 men aged 40 years and above, with prostate diseases, devoid of prostate-related surgeries, recruited from urology clinic, in the University of Calabar Teaching Hospital, from October 2023 to April, 2024. Data was collected using an interviewer-administered questionnaire after consent. Blood samples were analyzed for vitamin D and prostate-specific antigens.

Results

Most participants, 43 (42.2%) were 61-70 years, and over half 55 (53.9%) had a tertiary education. Majority, 52 (50.9%), had benign prostatic hyperplasia, 40 (39.2%) had prostate cancer, and 10 (9.8%) had prostatitis. Overall, 71(69.61%) had sufficient vitamin D levels (50–100 nMol/L), and 10(9.8%) had deficiency. Higher proportion of deficiency was found in the 1-5 years treatment category. Elevated prostate-specific antigen (>10 ng/mL), occurred in 52 (50.98%) of participants, predominantly below six months of treatment. There was no statistically significant association between sociodemographic characteristics of respondents, treatment categories, and PSA with vitamin D levels (p > 0.05).

Conclusion

Majority of patients had sufficient vitamin D levels. However, vitamin D deficiency was higher in the prostate cancer group and the1-5 years treatment category. Further studies are suggested to understand vitamin D’s long-term role in prostate disease management.

Zitieren

APA

ES, E., LE, E., AB, E., OG, I., K, S., & O, O. (2026). Vitamin D status in patients treated for prostate diseases in a tertiary hospital, in Calabar, south-south, Nigeria. Ibom Medical Journal, 19(3), 669-676. https://doi.org/10.61386/imj.v19i3.1198

Vancouver

ES E, LE E, AB E, OG I, K S, O O. Vitamin D status in patients treated for prostate diseases in a tertiary hospital, in Calabar, south-south, Nigeria. Ibom Medical Journal. 2026;19(3):669-676. doi:10.61386/imj.v19i3.1198

BibTeX
@article{ES2026,
  author = {ES, Eyam and LE, Eyam and AB, Ene and OG, Inyang and K, Saidu and O, Oaclayanju},
  title = {Vitamin D status in patients treated for prostate diseases in a tertiary hospital, in Calabar, south-south, Nigeria},
  journal = {Ibom Medical Journal},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {669--676},
  doi = {10.61386/imj.v19i3.1198}
}
Kostenlos starten →